Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting

F I Wang1, J O Fleming, M M Lai

  • 1Department of Neurology, School of Medicine, University of Southern California, Los Angeles 90033.

Virology
|February 1, 1992
PubMed

Insights

Mouse hepatitis virus (MHV) spike protein mutations influence its ability to cause encephalitis and demyelination. Multiple sites on the S protein interact to determine MHV neuropathogenicity.

Area of Science:

  • Virology
  • Neuroscience
  • Molecular Biology

Background:

  • Mouse hepatitis virus (MHV), a coronavirus, is known to cause central nervous system disease, including encephalitis and demyelination, in rodents.
  • The MHV spike (S) protein is a key factor in determining viral tropism and pathogenicity.
  • Understanding the molecular mechanisms underlying MHV neuropathogenesis is crucial for developing effective countermeasures.

Purpose of the Study:

  • To investigate the molecular basis of MHV neuropathogenesis by analyzing the spike protein gene sequences of neutralization-resistant MHV variants.
  • To identify specific mutations in the S protein associated with distinct neuropathological outcomes (encephalitis vs. demyelination).

Main Methods:

  • Selection of MHV JHM strain variants resistant to specific monoclonal antibodies (MAbs) targeting the S protein.
  • Sequencing of the spike protein gene from parental and variant MHV strains.
  • Correlation of identified mutations with observed neuropathological phenotypes (encephalitis, demyelination, virulence).

Main Results:

  • Variant 2.2-V-1, with a mutation in the S2 subunit (NT 3340), primarily caused demyelination.
  • Variant 7.2-V-1, with mutations in the S1 subunit (NT 1766, 1950), primarily caused encephalitis.
  • A double mutant (2.2/7.2-V-2) with a deletion in S1 and a mutation in S2 showed attenuated virulence and reduced demyelination.
  • Analysis of revertants and comparison with other studies suggest that multiple S protein sites interact to determine demyelinating potential.

Conclusions:

  • At least two distinct regions of the MHV S protein contribute to its neuropathogenicity.
  • The ability of JHM viruses to induce demyelination is likely determined by the interaction of multiple sites on the S gene, not a single site.
  • Sequence microheterogeneity within the S gene, particularly in the S1 region, may also contribute to variations in biological properties and neuropathogenesis.